Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Neuro-Oncology|April 1, 2006
Cystemustine in recurrent high grade gliomaX Durando, E Thivat, H Roché, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Neoadjuvant chemotherapy in 126 operable breast cancersE Bélembaogo, V Feillel, P Chollet, et al.
American Journal of Clinical Oncology|June 1, 1997
Adjuvant chemotherapy with doxorubicin-containing regimen for 326 stage II breast cancers: 15-year resultsJ P Ferrière, S Charrier, H Curé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patientsE Cellarier, C Terret, P Labarre, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: univariate and multivariate analysisJ Attia-Sobol, J P Ferrière, H Curé, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Clinical and pathological response to primary chemotherapy in operable breast cancerP Chollet, S Charrier, E Brain, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|November 21, 2000
[Assessment of different histoprognosis grading systems for primary ovarian cancer: 100 patients given the same treatment for primary ovarian adenocarcinoma]F Penault-Llorca, O Levrel, A Clémenson, et al.
Bone Marrow Transplantation|November 27, 2007
Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancerP Biron, M Durand, H Roché, et al.
British Journal of Cancer|October 2, 2003
Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer?P Chollet, S Amat, E Belembaogo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancerH Curé, V Chevalier, A Adenis, et al.
Pageof 4